Literature DB >> 20216315

High-risk localized prostate cancer: role of radical prostatectomy.

Robert L Grubb1, Adam S Kibel.   

Abstract

PURPOSE OF REVIEW: The paucity of randomized trials comparing curative management strategies for high-risk prostate cancer makes treatment decisions in this patient population difficult. Although in the past, high-risk patients have primarily been sent for radiation therapy due to concerns that surgery was not likely to be curative and associated with high side-effect profile, there is renewed interest in radical prostatectomy as the primary treatment for high-risk disease. RECENT
FINDINGS: Multiple case series have recently been reported that demonstrate the long-term efficacy of radical prostatectomy in a high-risk population with 15-year prostate cancer-specific survival of over 80%. Comparisons of different treatment options using nonrandomized trials demonstrate improved outcomes with surgery compared with watchful waiting or radiation therapy.
SUMMARY: Radical prostatectomy is an acceptable treatment alterative, which provides long-term durable disease control for men with high-risk prostate carcinoma.

Entities:  

Mesh:

Year:  2010        PMID: 20216315     DOI: 10.1097/MOU.0b013e3283384101

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  5 in total

1.  Radical Prostatectomy and Pelvic Lymph Node Dissection in Kaiser Permanente Southern California: 15-Year Experience.

Authors:  Pooya Banapour; Andrew Schumacher; Jane C Lin; David S Finley
Journal:  Perm J       Date:  2019

2.  Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer.

Authors:  Karen E Knudsen; William Kevin Kelly
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

3.  Do positive surgical margins predict biochemical recurrence in all patients without adjuvant therapy after radical prostatectomy?

Authors:  Jun Woo Lee; Jae Hyun Ryu; Yun Beom Kim; Seung Ok Yang; Jeong Kee Lee; Tae Young Jung
Journal:  Korean J Urol       Date:  2013-08-07

4.  Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center.

Authors:  Olivier Riou; Pascal Fenoglietto; Benoit Laliberté; Cathy Menkarios; Carmen Llacer Moscardo; Meng Huor Hay; Norbert Ailleres; Jean-Bernard Dubois; Xavier Rebillard; David Azria
Journal:  ISRN Urol       Date:  2012-03-20

Review 5.  The role of radical prostatectomy in high-risk prostate cancer.

Authors:  Byung Ha Chung
Journal:  Prostate Int       Date:  2013-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.